278 related articles for article (PubMed ID: 23230755)
1. [Dynamic changes of MMP-1, MMP-9 and TIMP-1 in the refractory diabetic dermal ulcers treated by autologous Platelet-rich gel].
He LP; Wang C; Chen DW; Li XJ; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):757-61. PubMed ID: 23230755
[TBL] [Abstract][Full Text] [Related]
2. [Impact of topical application of autologous platelet-rich gel on medical expenditure and length of stay in hospitals in diabetic patients with refractory cutaneous ulcers].
Li L; Wang C; Wang Y; He LP; Yang YZ; Chen LH; Chen DW; Li XJ; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):762-5. PubMed ID: 23230756
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it].
Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451
[TBL] [Abstract][Full Text] [Related]
4. [Study on the mechanism of autologous platelet-rich gel to treat the refractory diabetic dermal ulcers].
Yuan NB; Long Y; Zhang XX; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):292-4. PubMed ID: 19462910
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Autologous Platelet-Rich Gel on the Dynamic Changes of the Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 Expression in the Diabetic Chronic Refractory Cutaneous Ulcers.
Li L; Chen D; Wang C; Liu G; Ran X
J Diabetes Res; 2015; 2015():954701. PubMed ID: 26221614
[TBL] [Abstract][Full Text] [Related]
6. [Application of autologous platelet-rich gel to refractory chronic diabetic cutaneous ulcers].
Yuan N; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Apr; 21(4):426-9. PubMed ID: 17546893
[TBL] [Abstract][Full Text] [Related]
7. Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.
Li Z; Guo S; Yao F; Zhang Y; Li T
J Diabetes Complications; 2013; 27(4):380-2. PubMed ID: 23357650
[TBL] [Abstract][Full Text] [Related]
8. Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: A prospective, randomized clinical trial.
Li L; Chen D; Wang C; Yuan N; Wang Y; He L; Yang Y; Chen L; Liu G; Li X; Ran X
Wound Repair Regen; 2015; 23(4):495-505. PubMed ID: 25847503
[TBL] [Abstract][Full Text] [Related]
9. [The preliminary application of autologous platelet-rich gel used to treat refractory diabetic dermal ulcer].
Yuan NB; Wang C; Wang Y; Yu TT; Shu SQ; Liu M; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):900-3. PubMed ID: 17953386
[TBL] [Abstract][Full Text] [Related]
10. [Protein expressions of matrix metalloproteinase-9 and its inhibitor and their ratio changes in wound healing of patients with stages Ⅲ and Ⅳ pressure ulcers].
Wang Y; Li X; Zhao W; Gao ZZ; Zheng MJ; Pang YL; Chen ZY
Zhonghua Shao Shang Za Zhi; 2019 Oct; 35(10):746-751. PubMed ID: 31658546
[No Abstract] [Full Text] [Related]
11. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.
Lobmann R; Ambrosch A; Schultz G; Waldmann K; Schiweck S; Lehnert H
Diabetologia; 2002 Jul; 45(7):1011-6. PubMed ID: 12136400
[TBL] [Abstract][Full Text] [Related]
12. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
Nwomeh BC; Liang HX; Cohen IK; Yager DR
J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing.
Muller M; Trocme C; Lardy B; Morel F; Halimi S; Benhamou PY
Diabet Med; 2008 Apr; 25(4):419-26. PubMed ID: 18387077
[TBL] [Abstract][Full Text] [Related]
14. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic bovine whey extract modulates matrix metalloproteinase-2, -9, and tissue inhibitor of matrix metalloproteinase-2 levels in chronic leg ulcers.
Varelias A; Cowin AJ; Adams D; Harries RH; Cooter RD; Belford DA; Fitridge RA; Rayner TE
Wound Repair Regen; 2006; 14(1):28-37. PubMed ID: 16476069
[TBL] [Abstract][Full Text] [Related]
16. Autologous platelet-rich gel treatment for diabetic chronic cutaneous ulcers: A meta-analysis of randomized controlled trials.
Li Y; Gao Y; Gao Y; Chen D; Wang C; Liu G; Yang X; Ran X
J Diabetes; 2019 May; 11(5):359-369. PubMed ID: 30182534
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.
Lobmann R; Zemlin C; Motzkau M; Reschke K; Lehnert H
J Diabetes Complications; 2006; 20(5):329-35. PubMed ID: 16949521
[TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
[TBL] [Abstract][Full Text] [Related]
19. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.
Dougherty EJ
Adv Skin Wound Care; 2008 Dec; 21(12):568-75. PubMed ID: 19065083
[TBL] [Abstract][Full Text] [Related]
20. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
